Notably, the fluorescence intensity in z-FA-FMK-treated PC-3 tumor cells was 26.5% reduced, compared to the Apo-S-Ac3ManNAz/TRAIL-treated PC-3 tumor cells (Figure S10b). Here, TNFSF10 is linked to neoplasm.